Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Dermatology
Thoracic Malignancies
Questions discussed in this category
Would you still consider durvalumab consolidation after definitive chemoradiation for patients with Stage III NSCLC who are on stable weekly methotrexate dosing for psoriasis/psoriatic arthritis?
1 Answer available
12241
Papers discussed in this category
J Immunother Cancer,
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy.
Related Topics in Dermatology
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Gastrointestinal Cancers
Melanoma/Skin Cancer
Non-malignant Disease
Pediatric Oncology